Scintigraphic non-invasive diagnosis of amyloid cardiomyopathy

Article Sidebar

PDF HTML
Submitted: September 18, 2019
Published: Oct 4, 2019
DOI: 10.29328/journal.jccm.1001058
Keywords:
Computed tomography, DM, Coronary artery, Atherosclerosis
Crossref
Scopus
Google Scholar
Europe PMC

Main Article Content

Laroussi Mohamed-Salem*
Department of Nuclear Medicine, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain
Tomás E Rodríguez-Locarno
Department of Nuclear Medicine, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain
Tatiana Moreno-Monsalve
Department of Nuclear Medicine, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain
Isabel Castellón-Sánchez
Department of Nuclear Medicine, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain
José F Contreras-Gutiérrez
Department of Nuclear Medicine, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain
Antonia Claver-Valderas
Department of Nuclear Medicine, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain

Article Details

Mohamed-Salem, L., Rodríguez-Locarno, T. E., Moreno-Monsalve, T., Castellón-Sánchez, I., Contreras-Gutiérrez, J. F., & Claver-Valderas, A. (2019). Scintigraphic non-invasive diagnosis of amyloid cardiomyopathy. Journal of Cardiology and Cardiovascular Medicine, 4(3), 156–158. https://doi.org/10.29328/journal.jccm.1001058
Case Reports

Copyright (c) 2019 Mohamed-Salem L, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Singh V, Falk R, Di Carli MF, Kijewski M, Rapezzi C, et al. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J Nucl Cardiol. 2019; 26: 158-173. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30569412

Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005; 112: 2047-2060. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16186440

Patel KS, Hawkins PN. Cardiac amyloidosis: where are we today? J Intern Med. 2015; 278: 126-144. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26077367

Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, et al. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. Circ Heart Fail. 2019; 12: e006075. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31480867

Mohamed-Salem L, Santos-Mateo JJ, Sanchez-Serna J, Hernández-Vicente Á, Reyes-Marle R, et al. Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. Int J Cardiol. 2017; 270: 192-196. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29903517

Mohamed-Salem L, Moreno-Monsalve T, Castellón-Sánchez MI, Claver-Valderas MA, Pascual-Figal DA. Non-biopsy diagnosis of familial amyloid cardiomyopathy. J Nucl Cardiol. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30945209

Haro-del F, Sánchez A, Gómez M, García P, Salas-Antón C, et al. Role of cardiac scintigraphy with 99mTC-DPD in the discrimination of the cardiac amyloidosis subtype. Rev Esp Cardiol. 2012; 65: 440-446.

Zhao L, Tian Z, Fang Q. Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis. BMC Cardiovascular Disorders. 2016; 16: 12. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27267362

Brownrigg J, Lorenzini M, Lumley M, Elliott P. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis. ESC Heart Failure. 2019.

Ertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, et al. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015; 66: 2451-2466. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26610878

Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016; 133: 2404-2412. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27143678